Skip to content

Welcome to Discover Pharma! Today is : October 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends maralixibat for Alagille syndrome itching

    read more
  • Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Mursla Bio validates liver-specific liquid biopsy platform

    read more
  • Clinical & Regulatory,Medical devices

    E2 secures FDA clearance for pulmonary embolism thrombectomy system

    read more
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Carterra and AstraZeneca target AI-driven drug discovery

    read more
  • Biotech & Pharma Business,Research & Development

    Biopharma dealmaking outlook improves despite investor caution

    read more
  • Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    SurVaxM improves survival in Phase 2b glioblastoma trial

    read more
  • Research & Development,Therapeutic Areas

    Lab-grown human neuromuscular junctions advance MND drug discovery

    read more
  • Clinical & Regulatory,Research & Development

    Olink assay correlates with ELISA for measuring endothelin-1

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study

    read more
  • Digital & Data,Drug Discovery & Development,Research & Development

    Shift Bioscience publishes AI virtual cell framework for target discovery

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Aravax to present Phase 2 peanut allergy data in November

    read more
  • Manufacturing & Supply Chain,Opinion & Events

    CPHI Milan to focus on practical sustainability across pharma supply chains

    read more
  • Clinical & Regulatory

    Brenntag and dsm-firmenich agree global GMP vitamin deal

    read more
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Laverock Therapeutics expands into in vivo CAR-T and genetic medicine

    read more
  • Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Trixeo approved in EU for asthma

    read more
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Aravax to present Phase 2 peanut allergy data in November
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • CPHI Milan to focus on practical sustainability across pharma supply chains
    Categories: Manufacturing & Supply Chain, Opinion & Events
  • Brenntag and dsm-firmenich agree global GMP vitamin deal
    Categories: Clinical & Regulatory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top